HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence for prevention of borderline leprosy reactions by dapsone.

Abstract
68 patients were included in a prospective study of the treatment of borderline leprosy. 34 were treated with dapsone 5 mg daily, and 34 with 50 mg daily. Reversal reactions developed in 11 of those on 5 mg daily and in 3 of those on 50 mg daily. The statistically significant difference between the two treatment groups indicates that, contrary to previous teaching, dapsone given in higher dosage does not predispose patients to reversal reactions and indeed may prevent them.
AuthorsR S Barnetson, J M Pearson, R J Rees
JournalLancet (London, England) (Lancet) Vol. 2 Issue 7996 Pg. 1171-2 (Nov 27 1976) ISSN: 0140-6736 [Print] England
PMID62998 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Dapsone
Topics
  • Adolescent
  • Adult
  • Dapsone (administration & dosage, therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hypersensitivity, Delayed (complications, prevention & control)
  • Leprosy (complications, drug therapy, immunology)
  • Male
  • Middle Aged
  • Neuritis (etiology)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: